Dowsett M - Search Results

1

Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistance.

Dunbier AK, Ghazoui Z, Anderson H, Salter J, Nerurkar A, Osin P, A'hern R, Miller WR, Smith IE, Dowsett M. Dunbier AK, et al. Among authors: dowsett m. Clin Cancer Res. 2013 May 15;19(10):2775-86. doi: 10.1158/1078-0432.CCR-12-1000. Epub 2013 Mar 14. Clin Cancer Res. 2013. PMID: 23493347 Free article.

2

Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention.

Harper-Wynne C, Ross G, Sacks N, Salter J, Nasiri N, Iqbal J, A'Hern R, Dowsett M. Harper-Wynne C, et al. Among authors: dowsett m. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):614-21. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12101108 Clinical Trial.

3

Preoperative models to evaluate endocrine strategies for breast cancer.

Dowsett M. Dowsett M. Clin Cancer Res. 2003 Jan;9(1 Pt 2):502S-10S. Clin Cancer Res. 2003. PMID: 12538507 Review.

4

Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer.

Johnston SR, Head J, Pancholi S, Detre S, Martin LA, Smith IE, Dowsett M. Johnston SR, et al. Among authors: dowsett m. Clin Cancer Res. 2003 Jan;9(1 Pt 2):524S-32S. Clin Cancer Res. 2003. PMID: 12538510 Review.

5

Human epidermal growth factor receptor-2 and hormonal therapies: clinical implications.

Ring A, Dowsett M. Ring A, et al. Among authors: dowsett m. Clin Breast Cancer. 2003 Apr;4 Suppl 1:S34-41. doi: 10.3816/cbc.2003.s.013. Clin Breast Cancer. 2003. PMID: 12756077 Review.

6

Aromatase inhibitors in breast cancer.

Smith IE, Dowsett M. Smith IE, et al. Among authors: dowsett m. N Engl J Med. 2003 Jun 12;348(24):2431-42. doi: 10.1056/NEJMra023246. N Engl J Med. 2003. PMID: 12802030 Review. No abstract available.

7

Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer.

Johnston SR, Hickish T, Ellis P, Houston S, Kelland L, Dowsett M, Salter J, Michiels B, Perez-Ruixo JJ, Palmer P, Howes A. Johnston SR, et al. Among authors: dowsett m. J Clin Oncol. 2003 Jul 1;21(13):2492-9. doi: 10.1200/JCO.2003.10.064. J Clin Oncol. 2003. PMID: 12829668 Clinical Trial.

8

Role of biologic markers in patient selection and application to disease prevention.

Dowsett M, Ellis MJ. Dowsett M, et al. Am J Clin Oncol. 2003 Aug;26(4):S34-9. doi: 10.1097/00000421-200308001-00006. Am J Clin Oncol. 2003. PMID: 12902875

9

Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells.

Zabaglo L, Ormerod MG, Parton M, Ring A, Smith IE, Dowsett M. Zabaglo L, et al. Among authors: dowsett m. Cytometry A. 2003 Oct;55(2):102-8. doi: 10.1002/cyto.a.10071. Cytometry A. 2003. PMID: 14505315 Free article.

10

Origin and characteristics of adverse events in aromatase inhibition therapy for breast cancer.

Dowsett M. Dowsett M. Semin Oncol. 2003 Aug;30(4 Suppl 14):58-69. doi: 10.1016/s0093-7754(03)00300-2. Semin Oncol. 2003. PMID: 14513437 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters